Opus Genetics, Inc. (IRD) › Shareholders' EquityOpus Genetics, Inc. (IRD) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2001: $3.89M2002: $2.71M2003: $2.48M2004: -$564.2K2005: $4.83M2006: $3.21M2007: $958.2K2008: -$2.60M2009: $4.90M2010: $10.40M2011: $10.71M2012: $9.53M2013: $12.63M2014: $26.58M2015: $18.78M2016: $17.06M2017: $16.77M2018: -$1.70M2019: -$7.56M2020: -$13.47M2021: $22.22M2022: $46.24M2023: $49.91M2024: $6.72M2025: $15.35M$15.35M2001Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$15.35M+128.3%2024$6.72M-86.5%2023$49.91M+7.9%2022$46.24M+108.1%2021$22.22M+265.0%2020-$13.47M-78.1%2019-$7.56M-345.0%2018-$1.70M-110.1%2017$16.77M-1.7%2016$17.06M-9.1%2015$18.78M-29.4%2014$26.58M+110.5%2013$12.63M+32.4%2012$9.53M-10.9%2011$10.71M+3.0%2010$10.40M+112.0%2009$4.90M+288.4%2008-$2.60M-371.6%2007$958.2K-70.2%2006$3.21M-33.5%2005$4.83M+956.0%2004-$564.2K-122.8%2003$2.48M-8.7%2002$2.71M-30.3%2001$3.89M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share